The thesis
SilentDip rests on a clean, testable idea: a sharp price drop with no negative headline attached is usually noise, and noise reverts. The same drop carrying genuine bad news tends to keep drifting lower. So the strategy only buys when two conditions line up — oversold technicals and the absence of salient negative sentiment — then exits as the name mean-reverts to its SMA20 or as RSI normalizes.
The lineage is reassuringly academic. It builds on Clinch, He, Landsman & Li (SSRN working paper, Nov 2025), itself extending Chan's well-cited 2003 work on price reactions to news versus no-news. This is a documented anomaly, not a curve-fit hunch — a point in its favour.
Backtest and validation
Over 1,279 trading days the backtest returned 52.62% (final equity $15,262 from a $10k base), a 1.03 Sharpe, a 70.55% win rate across 294 trades, and a contained 10.38% max drawdown. Annualized, that 52.62% is a more sober 8.69% CAGR — respectable for a low-drawdown strategy, but not a rocket.
The validation is the strongest part of the story. All four walk-forward folds were positive, and crucially the strategy got better in the recent ones: fold 3 returned 26.26% (Sharpe 1.84) and fold 4 returned 16.75% (Sharpe 1.91). The most recent out-of-sample window posted a 1.91 Sharpe with just a 2.39% drawdown. A Probabilistic Sharpe Ratio of 0.991 says the backtest Sharpe is almost certainly above zero.
The risks
Two caveats temper the enthusiasm. First, the Deflated Sharpe Ratio is 0.563. After haircutting for 42 trials of multiple testing, confidence drops from "nearly certain" (PSR) to "barely a coin-flip edge" (DSR). It survives the gate, but only just.
Second, and more immediately: the live book is doing almost nothing. Six consecutive scheduled runs from Oct 19–26 each report 0 executed, 0 rejected, with roughly 85% of capital ($8,515 of ~$9,981) parked in cash. The only recent position is a single BAC buy (29 shares at $51) on Oct 14. Live total equity sits just below its $10k start — marginally underwater.
Read
That inactivity is arguably the strategy working as designed: no qualifying dips means no trades, and patience beats forcing bad entries. But it is also opportunity cost, and the high backtest win rate is characteristic of mean-reversion — many small wins punctuated by occasional sharp losses when a "no-news" drop turns out to be an early-news drop. The validation says the edge is real; the DSR and the current cash drag say to size it modestly and judge it over quarters, not weeks.